Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-061091

Options or other derivatives

  • Chief Executive Officer acquired 70,246 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ALLEN SIMON Chief Executive Officer 2022-12-09 Grant or award · Stock Option (right to buy) +70,246 70,246 D
Loading xslF345X03/doc4.xml…